McGrogan A, Franssen CF, de Vries CS (2011) The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant 26:414–430

Article  PubMed  Google Scholar 

Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368:2402–2414

Article  CAS  PubMed  Google Scholar 

Koyama A, Igarashi M, Kobayashi M (1997) Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases. Am J Kidney Dis 29:526–532

Article  CAS  PubMed  Google Scholar 

Li LS, Liu ZH (2004) Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int 66:920–923

Article  PubMed  Google Scholar 

Chang JH, Kim DK, Kim HW, Park SY, Yoo TH, Kim BS, Kang SW, Choi KH, Han DS, Jeong HJ, Lee HY (2009) Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience. Nephrol Dial Transplant 24:2406–2410

Article  PubMed  Google Scholar 

O’Shaughnessy MM, Hogan SL, Thompson BD, Coppo R, Fogo AB, Jennette JC (2018) Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey. Nephrol Dial Transplant 33:661–669

Article  PubMed  Google Scholar 

Willey CJ, Coppo R, Schaefer F, Mizerska-Wasiak M, Mathur M, Schultz MJ (2023) The incidence and prevalence of IgA nephropathy in Europe. Nephrol Dial Transplant 38:2340–2349

Article  PubMed  PubMed Central  Google Scholar 

Shibano T, Takagi N, Maekawa K, Mae H, Hattori M, Takeshima Y, Tanizawa T (2016) Epidemiological survey and clinical investigation of pediatric IgA nephropathy. Clin Exp Nephrol 20:111–117

Article  CAS  PubMed  Google Scholar 

Schena FP, Nistor I (2018) Epidemiology of IgA nephropathy: a global perspective. Semin Nephrol 38:435–442

Article  PubMed  Google Scholar 

Coppo R (2019) Pediatric IgA nephropathy in Europe. Kidney Dis (Basel) 5:182–188

Article  PubMed  PubMed Central  Google Scholar 

Barbour SJ, Espino-Hernandez G, Reich HN, Coppo R, Roberts IS, Feehally J, Herzenberg AM, Cattran DC, Oxford Derivation North American Validation and VALIGA Consortia (2016) The MEST score provides earlier risk prediction in lgA nephropathy. Kidney Int 89:167–175

Article  CAS  PubMed  Google Scholar 

Gadola L, Cabrera MJ, Garau M, Coitino R, Aunchayna MH, Noboa O, Alvarez MA, Balardini S, Desiderio G, Dibello N, Ferreiro A, Giro S, Luzardo L, Maino A, Orihuela L, Ottati MG, Urrestarazu A (2023) Long-term follow-up of an IgA nephropathy cohort: outcomes and risk factors. Ren Fail 45:2152694

Article  PubMed  PubMed Central  Google Scholar 

Kamei K, Harada R, Hamada R, Sakai T, Hamasaki Y, Hataya H, Ito S, Ishikura K, Honda M (2016) Proteinuria during follow-up period and long-term renal survival of childhood IgA nephropathy. PLoS One 11:e0150885

Article  PubMed  PubMed Central  Google Scholar 

Coppo R, Robert T (2020) IgA nephropathy in children and in adults: two separate entities or the same disease? J Nephrol 33:1219–1229

Article  PubMed  Google Scholar 

Working Group for National Survey on Status of Diagnosis and Treatment of Childhood Renal Diseases (2013) Multicenter investigation of therapeutic status of children with IgA nephropathy in China. Zhonghua Er Ke Za Zhi 51:486–490

Google Scholar 

Wu H, Fang X, Xia Z, Gao C, Peng Y, Li X, Zhang P, Kuang Q, Wang R, Wang M (2020) Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience. J Nephrol 33:1263–1273

Article  PubMed  Google Scholar 

Rauen T, Eitner F, Fitzner C, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JF, Hilgers RD, Floege J, STOP-IgAN Investigators (2015) Intensive supportive care plus immunosuppression in IgA nephropathy. N Engl J Med 373:2225–2236

Article  CAS  PubMed  Google Scholar 

Rauen T, Wied S, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, Panzer U, Budde K, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JFE, Hilgers RD, Floege J, STOP-IgAN Investigators (2020) After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy. Kidney Int 98:1044–1052

Article  CAS  PubMed  Google Scholar 

Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, Monaghan H, Zhao M, Barbour S, Reich H, Cattran D, Glassock R, Levin A, Wheeler D, Woodward M, Billot L, Chan TM, Liu ZH, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Wang HY, Perkovic V, TESTING Study Group (2017) Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA 318:432–442

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100:S1–S276

Article  Google Scholar 

Wang T, Ye F, Meng H, Zhang L, Jin X (2012) Comparison of clinicopathological features between children and adults with IgA nephropathy. Pediatr Nephrol 27:1293–1300

Article  PubMed  Google Scholar 

Cambier A, Rabant M, El Karoui K, Peuchmaur M, Servais A, Hertig A, Deschenes G, Salomon R, Hogan J, Robert T (2020) Clinical and histological differences between adults and children in new onset IgA nephropathy. Pediatr Nephrol 35:1897–1905

Article  PubMed  Google Scholar 

Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H, Feehally J, IgAN Classification Working Group of the International IgA Nephropathy Network and the Renal Pathology Society 11; Conference Participants (2017) Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int 91:1014–1021

Article  PubMed  Google Scholar 

Flynn JT, Kaelber DC, Baker-Smith CM, Subcommittee on screening and management of high blood pressure in children et al (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140:e20171904

Article  PubMed  Google Scholar 

Grams ME, Sang Y, Ballew SH, Matsushita K, Astor BC, Carrero JJ, Chang AR, Inker LA, Kenealy T, Kovesdy CP, Lee BJ, Levin A, Naimark D, Pena MJ, Schold JD, Shalev V, Wetzels JFM, Woodward M, Gansevoort RT, Levey AS, Coresh J (2019) Evaluating glomerular filtration rate slope as a surrogate end point for ESKD in clinical trials: an individual participant meta-analysis of observational data. J Am Soc Nephrol 30:1746–1755

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greene T, Ying J, Vonesh EF, Tighiouart H, Levey AS, Coresh J, Herrick JS, Imai E, Jafar TH, Maes BD, Perrone RD, Del Vecchio L, Wetzels JFM, Heerspink HJL, Inker LA (2019) Performance of GFR slope as a surrogate end point for kidney disease progression in clinical trials: a statistical simulation. J Am Soc Nephrol 30:1756–1769

Article  PubMed  PubMed Central  Google Scholar 

Stuart EA (2010) Matching methods for causal inference: a review and a look forward. Stat Sci 25:1–21

Article  PubMed  PubMed Central  Google Scholar 

Rubin DB (2001) Using propensity scores to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Method 2:169–188

Article  Google Scholar 

Okada K, Funai M, Kawakami K, Kagami S, Yano I, Kuroda Y (1990) IgA nephropathy in Japanese children and adults: a comparative study of clinicopathological features. Am J Nephrol 10:191–197

Article  CAS  PubMed  Google Scholar 

Cambier A, Rabant M, Peuchmaur M, Hertig A, Deschenes G, Couchoud C, Kolko A, Salomon R, Hogan J, Robert T (2018) Immunosuppressive treatment in children with IgA nephropathy and the clinical value of podocytopathic features. Kidney Int Rep 3:916–925

Article  PubMed  PubMed Central  Google Scholar 

Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Coppo R, Troyanov S, Camilla R, Hogg RJ, Cattran DC, Cook HT, Feehally J, Roberts IS, Amore A, Alpers CE, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D’Agati V, D’Amico G, Emancipator SN, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo AB, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2010) The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int 77:921–927

Article